COLLABORATION BETWEEN NURSES AND PHARMACISTS IN PROVIDING MEDICATION TO HEALTHCARE FACILITIES
Main Article Content
Keywords
Cooperation between the nurse and the pharmacist, in supplying medications, health facility.
Abstract
The objective of the study was to determine the nurse's relationship with the role assigned to him regarding medications, the chemist's relationship with the various technical groups regarding medicines, and the degree of cooperation and coordination between the chemist and these groups with regard to securing medicines for departments of the health facility. A survey was developed using the Google Drive application and disseminated through the messaging application WhatsApp to health practitioners in Mecca who were the intended audience. A total of 750 questionnaires were distributed, and 700 responses were collected from the targeted population, which comprised residents of Mecca aged 25-55 years.
Downloads
References
1- Harris MF, Zwar NA. Care of patients with chronic disease: the challenge for general practice. Med J Aust 2007; 187: 104–107. 2- Zwarenstein M et al. Interprofessional collaboration: effects of practice-based interventions on professional practice and healthcare outcomes (Review). Cochrane Database Syst Rev 2009; 3: CD000072. 3- Wagner EH. Effective teamwork and quality of care. Med Care 2004; 42: 1037–1039. 4- Wagner EH et al. Organising care for patients with chronic illness. Milbank Q 1996; 74: 511–526. 5- Shaffer J, Wexler LF. Reducing lowdensity lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care.Arch Intern Med 1995; 155: 2330–2335. 6- Bogden PE et al. The physician and pharmacist team. An effective approach to cholesterol reduction. J Gen Intern Med 1997; 12: 158–164. 7- Gattis WA et al. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med 1999; 159: 1939–1945. 8- Chan DS et al. Multidisciplinary education and management program for children with asthma. Am J Health Syst Pharm 2001; 58: 1413–1417. 9- Borenstein JE et al. Physicianpharmacist comanagement of hypertension: a randomized, comparative trial. Pharmacotherapy 2003; 23: 209– 216. 10- Strasser F et al. Impact of a half-day multidisciplinary symptom control and palliative care outpatient clinic in a comprehensive cancer center on recommendations, symptom intensity, and patient satisfaction: a retrospective descriptive study. J Pain Symptom Manage 2004; 27: 481–491. 11- Chelminski PR et al. A primary care, multi-disciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidity. BMC Health Serv Res 2005; 5: 3. 12- Garrett DG, Bluml BM. Patient selfmanagement program for diabetes: first-year clinical, humanistic, and economic outcomes. J Am Pharm Assoc 2005; 45: 130–137. 13- Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmaco-ther 2005; 39: 1828. 14- -McWhorter L,Oderda GM. Providing diabetes education and care to underserved patients in a collaborative practice at a utah community health center. Pharmacotherapy 2005; 25: 96-109. 15- Straka RJ et al. Achieving cholesterol target in a managed care organization (ACTION) trial. Pharmacotherapy 2005; 25: 360–371. 16- Australian Government Medicare Australia. Medicare Benefits Schedule (MBS) 2007. http://www.health.gov. au/mbsonline (accessed 29 April 2008). 17- Gittell JH et al. Impact of relational coordination on quality of care, postoperative pain & functioning, and length of stay: a nine-hospital study of surgical patients. Med Care 2000; 38: 807–819. 18- Cave DG. Vertical integration models to prepare health systems for capitation Health Manage Rev 1995; 20: 26–39. 19- Leatt P et al. Strategic Alliances in Health Care. Ottawa: Canadian College of Heatlh Services Executives, 1996. 20- Robinson J, Casalino L. Vertical integration and organizational network in health care. Health Aff 1996; 15: 7– 22. 21- Shortell S et al. Remaking Health Care in America. San Francisco, CA: Jossey Bass Publishers, 1996. 22- Sicotte C et al. Interdisciplinary collaboration within Quebec community health care centres. Soc Sci Med 2002; 55: 991–1003. 23- Cipolle RJ, Strand LM, Morley PC. In: Pharmaceutical Care Practice the Clinician’s Guide, 2nd edn. New York, NY: The McGraw-Hill Companies, Inc., 2004. 24- Task Force on Medicines Partnership and The National Collaborative Medicines Management, Services Programme. Room for Review: A guide to medication review: the agenda for patients, practitioners and managers. 2002. Available at http://www.npc.nhs.uk/review_medicines/intro/resources/ room_for_review.pdf (last accessed 12 October 2011). 25- Karapinar-Carkit F, Borgsteede SD, Zoer J, Smit HJ, Egberts AC, van den Bemt PM. Effect of medication reconciliation with and without patient counseling on the number of pharmaceutical interventions among patients discharged from the hospital. Ann Pharmacother 2009; 43: 1001–10. 26- Medicines PP. A Guide to Medication Review 2008. 2008. Available at http://www.npc.co.uk/review_medicines/ intro/resources/agtmr_web1.pdf (last 12 accessed October 2011). 27- Alserahy, Hassan Awad, et al (2008), The thinking and scientific research, Scie ntific Publishing Center, King Abdul-Aziz University in Jeddah, the first edition 28-Al Zoghbi, Muhammad and AlTalvah, Abas (2000), Statistical system understanding and analysis of statistical data, first edition, Jordon- Amman 29-. Kadasah, N.A.; Chirwa, G.C.; et al. Knowledge, Attitude and Practice Toward COVID-19 Among the Public in the Kingdom of Saudi Arabia: A Cross-Sectional Study. Front. Public Health 2020, 8, 217.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.